Haemato AG Stock
Your prediction
Haemato AG Stock
So far the community has only identified positive things for Haemato AG stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Haemato AG in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Haemato AG vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Haemato AG | - | - | - | - | - | - | - |
MPH Health Care AG | 0.000% | 2.857% | -1.818% | 36.709% | 30.120% | -22.857% | -48.325% |
Biotest AG ST | 0.480% | 0.971% | -1.422% | -3.256% | -1.887% | 43.448% | 68.421% |
Biotest AG VZ | -0.340% | 0.347% | 7.435% | -9.688% | -6.774% | -1.701% | 29.596% |
News
EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market
EQS-Adhoc: HAEMATO AG: Termination of listing in the Open Market
EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
EQS-News: HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
EQS-Adhoc: Termination of the botulinum toxin project
EQS-Adhoc: Termination of the botulinum toxin project